03:40 AM EDT, 10/15/2026 (MT Newswires) -- 4basebio (4BB.L) is aiming to raise at least 15 million pounds sterling from the sale of its shares through a placement, a subscription and a retail offering. The synthetic DNA manufacturing specialist said Thursday that the fundraise will comprise the placement of 2,664,080 new shares, the subscription for 1,025,239 new shares, and a retail offer for up to 97,087 new shares, all at the price of 5.15 pounds apiece. Net proceeds from the fundraise will be used to support the commercial development of the company's synthetic DNA, finance the group's operations, boost research and development capabilities, and support working capital. The share placement will involve an accelerated bookbuild process and is expected to close on Thursday, while the retail offer is expected to wrap up on Oct. 21. The fundraise plan is subject to shareholder approval at a general meeting scheduled for Nov. 6.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.